These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 17544512
1. The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalators. Kemp S, Wheate NJ, Buck DP, Nikac M, Collins JG, Aldrich-Wright JR. J Inorg Biochem; 2007 Jul; 101(7):1049-58. PubMed ID: 17544512 [Abstract] [Full Text] [Related]
2. DNA binding and biological activity of some platinum(II) intercalating compounds containing methyl-substituted 1,10-phenanthrolines. Brodie CR, Collins JG, Aldrich-Wright JR. Dalton Trans; 2004 Apr 21; (8):1145-52. PubMed ID: 15252653 [Abstract] [Full Text] [Related]
4. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes. Siddik ZH, al-Baker S, Thai G, Khokhar AR. Anticancer Drug Des; 1994 Apr 21; 9(2):139-51. PubMed ID: 8166929 [Abstract] [Full Text] [Related]
5. Novel platinum(II)-based anticancer complexes and molecular hosts as their drug delivery vehicles. Wheate NJ, Taleb RI, Krause-Heuer AM, Cook RL, Wang S, Higgins VJ, Aldrich-Wright JR. Dalton Trans; 2007 Nov 21; (43):5055-64. PubMed ID: 17992290 [Abstract] [Full Text] [Related]
6. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands. Kido Y, Khokhar AR, al-Baker S, Siddik ZH. Cancer Res; 1993 Oct 01; 53(19):4567-72. PubMed ID: 8402629 [Abstract] [Full Text] [Related]
7. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes. Choi S, Vastag L, Larrabee YC, Personick ML, Schaberg KB, Fowler BJ, Sandwick RK, Rawji G. Inorg Chem; 2008 Feb 18; 47(4):1352-60. PubMed ID: 18220340 [Abstract] [Full Text] [Related]
8. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O. Ali MS, Khan SR, Ojima H, Guzman IY, Whitmire KH, Siddik ZH, Khokhar AR. J Inorg Biochem; 2005 Mar 18; 99(3):795-804. PubMed ID: 15708801 [Abstract] [Full Text] [Related]
15. Role of carrier ligand in platinum resistance in L1210 cells. Gibbons GR, Page JD, Mauldin SK, Husain I, Chaney SG. Cancer Res; 1990 Oct 15; 50(20):6497-501. PubMed ID: 2208108 [Abstract] [Full Text] [Related]
16. Platinum(II) complexes with antitumoral/antiviral aromatic heterocycles: effect of glutathione upon in vitro cell growth inhibition. Papadia P, Margiotta N, Bergamo A, Sava G, Natile G. J Med Chem; 2005 May 05; 48(9):3364-71. PubMed ID: 15857142 [Abstract] [Full Text] [Related]
17. Identification of [PtCl2(phen)] binding modes in amyloid-β peptide and the mechanism of aggregation inhibition. Ma G, Huang F, Pu X, Jia L, Jiang T, Li L, Liu Y. Chemistry; 2011 Oct 04; 17(41):11657-66. PubMed ID: 21910144 [Abstract] [Full Text] [Related]
18. Phenanthroline derivatives with improved selectivity as DNA-targeting anticancer or antimicrobial drugs. Roy S, Hagen KD, Maheswari PU, Lutz M, Spek AL, Reedijk J, van Wezel GP. ChemMedChem; 2008 Sep 04; 3(9):1427-34. PubMed ID: 18537202 [Abstract] [Full Text] [Related]
20. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base. Roy S, Westmaas JA, Buda F, Reedijk J. J Inorg Biochem; 2009 Sep 04; 103(9):1278-87. PubMed ID: 19656572 [Abstract] [Full Text] [Related] Page: [Next] [New Search]